Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Manikis et al, 1995, Belgium | 129 trauma patients admitted to Intensive Care of a university-based hospital from 1992 to 1993. Overall mortality 22%. Arterial lactate measured. | Prospective cohort study | Mortality | Mean lactate: Survivors=2.8 (CI 0.4-10.2); Non-survivors=4.0 (CI 1-12.7); (p<0.05) | Study conducted in intensive care unit; early deaths within 24 hours were excluded; gunshot and stab wound injuries were not separated. |
Lavery et al, 2000, USA | 375 patients admitted to an urban trauma centre. Overall mortality 10%. Arterial and venous lactate measured. | Prospective cohort study | Correlation | Mean arterial lactate=3.11 (CI 2.67-3.55); Mean venous lactate=3.43 (CI 2.96-3.9); Correlation=0.94 (p=0.001) | Only 221 out of 375 patients had both arterial and venous lactate taken; patients with penetrating and blunt injuries were not separated. |
Mortality | Arterial lactate OR=1.1 (CI=0.98-1.15); Venous lactate OR=1.2 (CI=1.15-1.35) | ||||
Mortality | Venous lactate: SN=95%; SP=43%; PPV=16%; NPV=99% | ||||
Cerovic et al, 2003, Slovenia | 98 severely injured patients (ISS>16) admitted to Surgical Intensive Care Unit directly from the Surgical Emergency Unit. Overall mortality 25.5% (73 survivors and 25 non-survivors) Arterial lactate measured. | Prospective cohort study | Mortality | Lactate after 12 hours predicted survival (p=0.009); Lactate on admission did not prove to be a predictor of mortality. | Study conducted in intensive care unit; only severely injured patients were included; patients who died during the first 12 hours after admission were excluded; sample size small. |
Aslar et al, 2003, Turkey | 64 patients with torso trauma admitted to emergency department from 1996 to 1998. Overall mortality was 39.1% (39 survivors and 25 non-survivors) Arterial lactate measured. | Prospective cohort study | 30 day mortality | Univariate analysis of lactate > = 4: Chi square=29.34 (p<0.001); Logistic regression of lactate: OR=10.58 (p=0.0073) | Sample size small; patients with major head injury were excluded; patients included had a very high mortality; patients admitted for observation only were excluded. |
Pal et al, 2006, USA | 5995 patients admitted to the trauma registry of a university-based trauma centre from 1997 to 2003. Overall mortality was 3%. | Prospective cohort study | Mean lactate value | Survivors=3.0 +/- 0.04; Non-survivors=5.2 +/- 0.3 (p < 0.0001) | Patients with penetrating and blunt injuries were not separated. |
Elevated lactate > 2.0 | SN=85%; SP=38%; PPV=4%; Area under ROC curve=0.72 | ||||
Subgroup: died within 48 hours | PPV=11% | ||||
Subgroup: ISS>20 | Area under ROC curve=0.69 | ||||
Subgroup: age>50 | Area under ROC curve=0.65 | ||||
Kaplan and Kellum, 2004, USA | 282 Trauma patients requiring vascular repair from 1988 to 1997. Overall mortality was 22.7%. (218 survivors and 64 non-survivors) | Retrospective study | Mean lactate value | Survivors 3.6 (SD 1.5); nonsurvivors 11.1 (SD 3.6) (p,0.001) | Retrospective study; study focused on a specific group of patients requiring vascular repair lacking generalisablility; patients who died in the ED were excluded; penetrating and blunt injuries not separated. |
28-day mortality | Area under ROC curve 0.981 (CI 0.957–0.993) |